Showing results (171-180 of 313) with videos related to
Sort By:
Pageof 32
Plos One|April 16, 2011
Opposing roles for CD34 in B16 melanoma tumor growth alter early stage vasculature and late stage immune cell infiltrationSteven Maltby, Spencer Freeman, Matthew J Gold, et al.Journal of Cardiovascular Electrophysiology|March 19, 2004
Enhanced detection of arrhythmia vulnerability using T wave alternans, left ventricular ejection fraction, and programmed ventricular stimulation: a prospective study in subjects with chronic ischemic heart diseaseEric J Rashba, Ahmed F Osman, Karen Macmurdy, et al.Heart Rhythm|May 20, 2016
Impact of magnetic resonance imaging on ventricular tachyarrhythmia sensing: Results of the Evera MRI StudyMichael R Gold, Torsten Sommer, Juerg Schwitter, et al.Journal of Cardiovascular Electrophysiology|February 23, 2007
A prospective comparison of AV delay programming methods for hemodynamic optimization during cardiac resynchronization therapyMichael R Gold, Imran Niazi, Michael Giudici, et al.Journal of the American Heart Association|September 13, 2015
Effects of Cardiac Resynchronization Therapy on Cardiac Remodeling and Contractile Function: Results From Resynchronization Reverses Remodeling in Systolic Left Ventricular Dysfunction (REVERSE)Martin St John Sutton, Jeffrey Cerkvenik, Barry A Borlaug, et al.JACC. Clinical Electrophysiology|November 20, 2020
1-Year Prospective Evaluation of Clinical Outcomes and Shocks: The Subcutaneous ICD Post Approval StudyMartin C Burke, Johan D Aasbo, Mikhael F El-Chami, et al.Circulation. Arrhythmia and Electrophysiology|September 11, 2020
Permanent His Bundle Pacing Implantation Facilitated by Visualization of the Tricuspid Valve AnnulusMin Gu, Hongxia Niu, Yiran Hu, et al.ESC Heart Failure|August 14, 2020
Differences in clinical characteristics and reported quality of life of men and women undergoing cardiac resynchronization therapyBruce L Wilkoff, David Birnie, Michael R Gold, et al.Autoimmunity|October 9, 2012
Selective pharmacological inhibition of phosphoinositide 3-kinase p110delta opposes the progression of autoimmune diabetes in non-obese diabetic (NOD) miceCaylib A Durand, Martin J Richer, Kathrin Brenker, et al.European Journal of Heart Failure|January 10, 2018
The interaction of sex, height, and QRS duration on the effects of cardiac resynchronization therapy on morbidity and mortality: an individual-patient data meta-analysisCecilia Linde, John G F Cleland, Michael R Gold, et al.Pageof 32